Cerus reported $-1.45M in EBIT for its fiscal quarter ending in December of 2024.





Ebit Change Date
Cerus USD -1.45M 488K Dec/2024
GRIFOLS EUR 352.11M 20.18M Sep/2025
Haemonetics USD 67.4M 13.71M Dec/2025
Neogen USD -3.3M 2.08M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Plus Therapeutics USD -5.74M 1.26M Dec/2025
Quidel USD -37.3M 82.5M Dec/2025
STAAR Surgical USD -10.93M 35.38M Dec/2025
Terumo JPY 43.88B 1.21B Dec/2025
Utah Medical Products USD 2.44M 2M Dec/2025